Skip to main content

and
  1. Article

    Open Access

    Preventing long-term disability in CIDP: the role of timely diagnosis and treatment monitoring in a multicenter CIDP cohort

    Chronic inflammatory demyelinating polyneuropathy (CIDP) is an inflammatory disease affecting the peripheral nerves and the most frequent autoimmune polyneuropathy. Given the lack of established biomarkers or ...

    Paula Quint, Christina B. Schroeter, Felix Kohle, Menekse Öztürk in Journal of Neurology (2024)

  2. Article

    Open Access

    Correction to: Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management

    Tania Kümpfel, Katrin Giglhuber, Orhan Aktas, Ilya Ayzenberg in Journal of Neurology (2024)

  3. Article

    Open Access

    Prospective study validating a multidimensional treatment decision score predicting the 24-month outcome in untreated patients with clinically isolated syndrome and early relapsing–remitting multiple sclerosis, the ProVal-MS study

    In Multiple Sclerosis (MS), patients´ characteristics and (bio)markers that reliably predict the individual disease prognosis at disease onset are lacking. Cohort studies allow a close follow-up of MS historie...

    Antonios Bayas, Ulrich Mansmann, Begum Irmak Ön in Neurological Research and Practice (2024)

  4. Article

    Open Access

    Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management

    This manuscript presents practical recommendations for managing acute attacks and implementing preventive immunotherapies for neuromyelitis optica spectrum disorders (NMOSD), a rare autoimmune disease that cau...

    Tania Kümpfel, Katrin Giglhuber, Orhan Aktas, Ilya Ayzenberg in Journal of Neurology (2024)

  5. Article

    Open Access

    Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosis

    The term ‘neuromyelitis optica spectrum disorders’ (NMOSD) is used as an umbrella term that refers to aquaporin-4 immunoglobulin G (AQP4-IgG)-positive neuromyelitis optica (NMO) and its formes frustes and to a nu...

    Sven Jarius, Orhan Aktas, Ilya Ayzenberg, Judith Bellmann-Strobl in Journal of Neurology (2023)

  6. Article

    Open Access

    Somatosensory evoked potentials and magnetic resonance imaging of the central nervous system in early multiple sclerosis

    Somatosensory evoked potentials (SSEP) are still broadly used, although not explicitly recommended, for the diagnostic work-up of suspected multiple sclerosis (MS).

    Alexander Wuschek, Matthias Bussas, Malek El Husseini in Journal of Neurology (2023)

  7. Article

    Open Access

    Cognitive impairment in early MS: contribution of white matter lesions, deep grey matter atrophy, and cortical atrophy

    Cognitive impairment (CI) is a frequent and debilitating symptom in MS. To better understand the neural bases of CI in MS, this magnetic resonance imaging (MRI) study aimed to identify and quantify related str...

    Christina Engl, Laura Tiemann, Sophia Grahl, Matthias Bussas in Journal of Neurology (2020)

  8. No Access

    Article

    Efficacy of glatiramer acetate in neuromyelitis optica spectrum disorder: a multicenter retrospective study

    Glatiramer acetate (GA) is an approved therapy for relapsing–remitting multiple sclerosis, but its efficacy for the prevention of attacks in neuromyelitis optica spectrum disorder (NMOSD) remains unknown. We d...

    Ilya Ayzenberg, Joanna Schöllhammer, Robert Hoepner in Journal of Neurology (2016)

  9. Article

    Open Access

    Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS)

    Neuromyelitis optica (NMO, Devic’s syndrome), long considered a clinical variant of multiple sclerosis, is now regarded as a distinct disease entity. Major progress has been made in the diagnosis and treatmen...

    Corinna Trebst, Sven Jarius, Achim Berthele, Friedemann Paul in Journal of Neurology (2014)

  10. Article

    Open Access

    Novel SCARB2 mutation in action myoclonus-renal failure syndrome and evaluation of SCARB2mutations in isolated AMRF features

    Action myoclonus-renal failure syndrome is a hereditary form of progressive myoclonus epilepsy associated with renal failure. It is considered to be an autosomal-recessive disease related to loss-of-function m...

    Franziska Hopfner, Barbara Schormair, Franziska Knauf, Achim Berthele in BMC Neurology (2011)

  11. No Access

    Article

    Should we measure the bioavailability of interferon β in vivo in patients with multiple sclerosis?

    This commentary discusses a study by van der Voort et al. that tested the diagnostic value of in vivo interferon β (IFN-β) bioactivity screening in identifying patients with multiple sclerosis who have developed...

    Bernhard Hemmer, Achim Berthele in Nature Reviews Neurology (2009)

  12. No Access

    Article

    Spontaneous bilateral necrosis of the tongue: a manifestation of giant cell arteritis?

    Giant cell arteritis is a chronic vasculitis, which involves large- and medium-sized branches of the arteries originating from the aortic arch. This disease is a diagnostic challenge with a wide range of clini...

    Christian Schurr, Achim Berthele in European Archives of Oto-Rhino-Laryngology (2008)

  13. No Access

    Article

    Multicystic tumor in the fourth ventricle

    Clarissa U. Prazeres da Costa, Helga Gräfin von Einsiedel in Journal of Neurology (2006)